New Zealand markets open in 9 hours 9 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1200+0.1400 (+7.07%)
At close: 04:00PM EDT
2.1400 +0.02 (+0.94%)
After hours: 07:36PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-18,205
-15,426
-8,230
-24,384
-1,148
-
Depreciation & amortisation
28.813
5.468
2.135
2.468
2.321
-
Stock-based compensation
3,179
2,566
624.069
218.983
0
-
Change in working capital
2,114
1,653
195.206
-391.035
165.848
-
Accounts payable
-
2,434
1,132
-106.061
-3.83
-
Other working capital
-13,460
-11,424
-7,408
-1,590
-404.694
-
Other non-cash items
-
-
100
118.157
-
-
Net cash provided by operating activities
-13,106
-11,371
-7,408
-1,589
-404.694
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-52.089
-
-0.802
-
-7.308
Net cash used for investing activities
-354.002
-52.089
0
-0.802
0
-
Cash flows from financing activities
Debt repayment
-
0
-50
0
-
-
Common stock issued
31,538
15,696
3,389
18,649
0
-
Common stock repurchased
-
0
-99.963
0
-
-
Other financing activities
-
-234.616
-6.724
-
-
-
Net cash used provided by (used for) financing activities
31,293
15,464
3,232
18,849
0
-
Net change in cash
17,856
4,073
-4,208
17,253
-342.928
-
Cash at beginning of period
11,463
13,437
17,644
391.086
734.014
-
Cash at end of period
29,296
17,510
13,437
17,644
391.086
-
Free cash flow
Operating cash flow
-13,106
-11,371
-7,408
-1,589
-404.694
-
Capital expenditure
-
-52.089
-
-0.802
-
-7.308
Free cash flow
-13,460
-11,424
-7,408
-1,590
-404.694
-